A trial looking at different drugs for non small cell lung cancer (National Lung Matrix Trial)

Please note - this trial is no longer recruiting patients. We hope to add results when they are available.

Cancer type:

Lung cancer
Non small cell lung cancer
Secondary cancers

Status:

Closed

Phase:

Phase 2

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Professor Gary Middleton

Supported by

Cancer Research UK
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
Mirati Therapeutics
Pfizer
University of Birmingham

Other information

This is Cancer Research UK trial number CRUK/13/072.

If you have questions about the trial please contact our cancer information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

11152

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Last reviewed:

Rate this page:

Currently rated: 3.3 out of 5 based on 29 votes
Thank you!
We've recently made some changes to the site, tell us what you think